Compare BSIN & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSIN | DXR |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4M | 59.0M |
| IPO Year | 1995 | 1995 |
| Metric | BSIN | DXR |
|---|---|---|
| Price | $1.40 | $10.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 1.6K |
| Earning Date | N/A | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,379,000.00 | $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $8.56 |
| 52 Week High | $1.51 | $14.76 |
| Indicator | BSIN | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 63.92 | 43.57 |
| Support Level | $1.09 | $9.64 |
| Resistance Level | $1.50 | $11.16 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 71.79 | 4.78 |
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.